Cloudnine Eyes ₹11,000 Crore Valuation in PE Stake Sale

BANKINGFINANCE
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Cloudnine Eyes ₹11,000 Crore Valuation in PE Stake Sale

Global private equity firms TPG Capital and Permira are competing for a minority stake in maternity hospital chain Cloudnine. The potential deal values the company at ₹11,000 crore and includes a full exit for existing investor True North. This transaction comes as Cloudnine integrates its recent acquisition of Apollo Cradle to expand its national footprint.

Kids Clinic India, which operates the Cloudnine hospital chain, is moving toward a significant stake sale that could value the healthcare provider at approximately ₹11,000 crore. Global private equity majors TPG Capital and Permira have emerged as the primary contenders to acquire a minority stake in the company. This transaction follows the completion of the due diligence process, with binding bids expected to be submitted by mid-August.

Transition of Ownership and Equity

The proposed deal provides a full exit for private equity firm True North, which has been an investor in Cloudnine for over ten years. True North, which invested ₹400 crore in 2015, plans to divest its entire 25% stake in the hospital chain. In addition to purchasing these existing shares, the incoming investor is expected to subscribe to fresh equity worth 5% to 10% of the company. This capital infusion will likely be directed toward supporting the company's ongoing expansion and operational needs. Other major shareholders, including Temasek and TPG NewQuest, are expected to retain their current stakes, which account for about 52% of the company's total equity.

Business Growth and Network Expansion

Founded in 2006, Cloudnine has built a specialized focus on maternity and pediatric healthcare. The company has recently increased its scale significantly through the acquisition of Apollo Cradle and Apollo Fertility in May 2026. This expansion has brought its total network to more than 55 centers across India. For the fiscal year ending March 2026, the company reported revenue of ₹2,000 crore and an EBITDA of ₹300 crore, reflecting a 15% operating margin. The specialized mother and child healthcare sector in India is currently estimated at ₹30,000 crore, with industry projections suggesting a compound annual growth rate of 15%.

Strategic Monitorables

For investors observing the hospital and healthcare services sector, the integration of the acquired Apollo Cradle assets remains a critical factor. The ability of the management to maintain profit margins while scaling a network of over 55 centers will be essential for long-term performance. Investors may track the final valuation reached in this stake sale as a benchmark for the company’s current market position. Future updates on the official bidding results and the specific allocation of the new equity capital will provide further clarity on the company’s financial trajectory.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.